{"component": "definition", "props": {"groups": [{"samples": [{"hash": "99cDBoGzbdl", "uri": "/contracts/99cDBoGzbdl#study-documents", "label": "Clinical Research Services Agreement (Ym Biosciences Inc)", "score": 21.1697467488, "published": true}, {"hash": "77jC9BeWTNE", "uri": "/contracts/77jC9BeWTNE#study-documents", "label": "Clinical Research Services Agreement (Ym Biosciences Inc)", "score": 21.0, "published": true}, {"hash": "e47O0er59tH", "uri": "/contracts/e47O0er59tH#study-documents", "label": "Clinical Research Services Agreement (Ym Biosciences Inc)", "score": 18.0, "published": true}], "snippet": "means the documents produced by POI in connection with the Study that are necessary for the production of the final study report.", "snippet_links": [{"key": "the-documents", "type": "clause", "offset": [6, 19]}, {"key": "in-connection-with", "type": "clause", "offset": [36, 54]}, {"key": "the-study", "type": "definition", "offset": [55, 64]}, {"key": "necessary-for", "type": "definition", "offset": [74, 87]}, {"key": "the-production", "type": "clause", "offset": [88, 102]}, {"key": "final-study-report", "type": "definition", "offset": [110, 128]}], "size": 4, "hash": "aaaf3386e19d88086b724ff2f23d662f", "id": 1}, {"samples": [{"hash": "aY12aRevtqB", "uri": "/contracts/aY12aRevtqB#study-documents", "label": "Confidentiality Agreement (Adventrx Pharmaceuticals Inc)", "score": 20.0, "published": true}, {"hash": "ihc4gja7H2K", "uri": "https://savara.gcs-web.com/static-files/03a6b92f-0df2-4ebb-9bfe-03bf4973879e", "label": "savara.gcs-web.com", "score": 7.6584531143, "published": false}], "snippet": "means documents produced by Pharm-Olam in its conduct of the Study necessary for production of the Final Report.", "snippet_links": [{"key": "conduct-of-the-study", "type": "clause", "offset": [46, 66]}, {"key": "necessary-for", "type": "definition", "offset": [67, 80]}, {"key": "of-the-final-report", "type": "clause", "offset": [92, 111]}], "size": 2, "hash": "22b5f49d42500352948c28473b2be332", "id": 2}, {"samples": [{"hash": "8bv11GDZANu", "uri": "https://www.advaxis.com/static-files/d690873c-e8d4-40b7-911d-dc755a11764e", "label": "www.advaxis.com", "score": 9.9650924025, "published": false}, {"hash": "7YYYd4ERfpR", "uri": "https://www.sec.gov/Archives/edgar/data/1100397/000114420405018510/v019919_ex10-26.htm", "label": "Clinical Research Services Agreement (Advaxis, Inc.)", "score": 9.0, "published": false}], "snippet": "means the documents produced by POI in connection with the Study that are, in the sole discretion of POI, necessary for the production of the Final Study Report.", "snippet_links": [{"key": "the-documents", "type": "clause", "offset": [6, 19]}, {"key": "in-connection-with", "type": "clause", "offset": [36, 54]}, {"key": "the-study", "type": "definition", "offset": [55, 64]}, {"key": "sole-discretion", "type": "definition", "offset": [82, 97]}, {"key": "necessary-for", "type": "definition", "offset": [106, 119]}, {"key": "the-production", "type": "clause", "offset": [120, 134]}, {"key": "final-study-report", "type": "definition", "offset": [142, 160]}], "size": 2, "hash": "5b197a9d34125e59b7420f0b59204bd9", "id": 3}, {"samples": [{"hash": "be93Joelu7v", "uri": "/contracts/be93Joelu7v#study-documents", "label": "Clinical Trial Agreement", "score": 30.7100983319, "published": true}], "snippet": "means all records, accounts, CRF, notes, reports, data and IEC\u2019s and Regulatory Authority\u2019s communications (submission, approval and progress reports) collected or generated or used in connection with the Study and/or Study Drug, whether in written, electronic, oral or other form including all recorded original observations and notations of clinical activities and all other reports and records necessary for the evaluation and reconstruction of the Study. \u201eDokumenty ze studie\u201c znamenaj\u00ed ve\u0161ker\u00e9 z\u00e1znamy, v\u00fdkazy, formul\u00e1\u0159e CRF, pozn\u00e1mky, zpr\u00e1vy, \u00fadaje a komunikaci s NEK a regula\u010dn\u00edmi \u00fa\u0159ady (p\u0159edlo\u017een\u00ed, schv\u00e1len\u00ed a pr\u016fb\u011b\u017en\u00e9 zpr\u00e1vy) z\u00edskan\u00e9, vytvo\u0159en\u00e9 nebo pou\u017e\u00edvan\u00e9 v souvislosti se studi\u00ed a/nebo hodnocen\u00fdm p\u0159\u00edpravkem, a\u0165 ji\u017e v p\u00edsemn\u00e9, elektronick\u00e9, \u00fastn\u00ed nebo jin\u00e9 form\u011b, v\u010detn\u011b v\u0161ech zaznamenan\u00fdch p\u016fvodn\u00edch pozorov\u00e1n\u00ed a z\u00e1pis\u016f z klinick\u00fdch \u010dinnost\u00ed a v\u0161ech ostatn\u00edch zpr\u00e1v a z\u00e1znam\u016f pot\u0159ebn\u00fdch pro vyhodnocen\u00ed a rekonstrukci studie.", "snippet_links": [{"key": "all-records", "type": "clause", "offset": [6, 17]}, {"key": "regulatory-authority", "type": "definition", "offset": [69, 89]}, {"key": "progress-reports", "type": "definition", "offset": [133, 149]}, {"key": "in-connection-with", "type": "clause", "offset": [182, 200]}, {"key": "the-study", "type": "definition", "offset": [201, 210]}, {"key": "study-drug", "type": "definition", "offset": [218, 228]}, {"key": "clinical-activities", "type": "definition", "offset": [343, 362]}, {"key": "other-reports-and-records", "type": "clause", "offset": [371, 396]}, {"key": "necessary-for", "type": "definition", "offset": [397, 410]}, {"key": "the-evaluation", "type": "clause", "offset": [411, 425]}], "size": 2, "hash": "aa4662900f0ed539ebd9299996f385ec", "id": 4}, {"samples": [{"hash": "ajbT91pBzmu", "uri": "/contracts/ajbT91pBzmu#study-documents", "label": "Clinical Research Services Agreement (Advaxis, Inc.)", "score": 21.0, "published": true}], "snippet": "means the documents produced by APOTHECARIES in connection with the Study that are, in the sole discretion of APOTHECARIES, necessary for the production of the Final Study Report.", "snippet_links": [{"key": "the-documents", "type": "clause", "offset": [6, 19]}, {"key": "in-connection-with", "type": "clause", "offset": [45, 63]}, {"key": "the-study", "type": "definition", "offset": [64, 73]}, {"key": "sole-discretion", "type": "definition", "offset": [91, 106]}, {"key": "necessary-for", "type": "definition", "offset": [124, 137]}, {"key": "the-production", "type": "clause", "offset": [138, 152]}, {"key": "final-study-report", "type": "definition", "offset": [160, 178]}], "size": 1, "hash": "ac3c0fbc44a627ed92dd68b4dc9b5983", "id": 5}, {"samples": [{"hash": "8QbJel3aPZ4", "uri": "/contracts/8QbJel3aPZ4#study-documents", "label": "Master Clinical Study Agreement", "score": 21.0, "published": true}], "snippet": "means, with respect to each study, all documents other than the Protocol and Protocol Agreement that are provided by the Sponsor to an Institution, Principal Investigator or Personnel, which instruct, provide information or otherwise explain the conduct of such study. In the event of a conflict between a Study Document and the respective Protocol Agreement, the Protocol Agreement shall control. 1.18. \"Study Drug\" shall mean, with respect to each study, the drug that is the subject of such study, identified by chemical compound or brand name and as set forth and described more particularly in the Protocol Agreement applicable thereto. ARTICLE 2", "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "all-documents", "type": "definition", "offset": [35, 48]}, {"key": "the-protocol", "type": "clause", "offset": [60, 72]}, {"key": "protocol-agreement", "type": "definition", "offset": [77, 95]}, {"key": "the-sponsor", "type": "clause", "offset": [117, 128]}, {"key": "principal-investigator", "type": "definition", "offset": [148, 170]}, {"key": "or-personnel", "type": "definition", "offset": [171, 183]}, {"key": "provide-information", "type": "clause", "offset": [201, 220]}, {"key": "conduct-of", "type": "clause", "offset": [246, 256]}, {"key": "in-the-event-of-a", "type": "clause", "offset": [269, 286]}, {"key": "study-drug", "type": "definition", "offset": [405, 415]}, {"key": "subject-of", "type": "clause", "offset": [478, 488]}, {"key": "chemical-compound", "type": "definition", "offset": [515, 532]}, {"key": "brand-name", "type": "definition", "offset": [536, 546]}, {"key": "article-2", "type": "definition", "offset": [642, 651]}], "size": 1, "hash": "7a26886222cbf31932fcd744647a8fbe", "id": 6}, {"samples": [{"hash": "f5YjlChj3Xu", "uri": "/contracts/f5YjlChj3Xu#study-documents", "label": "Clinical Trial Agreement", "score": 27.8925271535, "published": true}], "snippet": "means all documents other than the Protocol that are provided by the Sponsor or CRO to Institution, Principal Investigator or Personnel, which instruct, provide information or otherwise explain the conduct of the Study.", "snippet_links": [{"key": "all-documents", "type": "definition", "offset": [6, 19]}, {"key": "the-protocol", "type": "clause", "offset": [31, 43]}, {"key": "the-sponsor", "type": "clause", "offset": [65, 76]}, {"key": "principal-investigator", "type": "definition", "offset": [100, 122]}, {"key": "or-personnel", "type": "definition", "offset": [123, 135]}, {"key": "provide-information", "type": "clause", "offset": [153, 172]}, {"key": "conduct-of-the-study", "type": "clause", "offset": [198, 218]}], "size": 1, "hash": "163f8cec763c8028013bcfd835a72fac", "id": 7}, {"samples": [{"hash": "c9nitPy2SbX", "uri": "/contracts/c9nitPy2SbX#study-documents", "label": "Master Services Agreement (Ym Biosciences Inc)", "score": 21.1697467488, "published": true}], "snippet": "means the documents produced by AAIPharma in connection with the Study.", "snippet_links": [{"key": "the-documents", "type": "clause", "offset": [6, 19]}, {"key": "in-connection-with", "type": "clause", "offset": [42, 60]}, {"key": "the-study", "type": "definition", "offset": [61, 70]}], "size": 1, "hash": "875db7718ac26efef27027dd1d78c504", "id": 8}, {"samples": [{"hash": "2n9WwAgZsoe", "uri": "/contracts/2n9WwAgZsoe#study-documents", "label": "Master Services Agreement (Ym Biosciences Inc)", "score": 21.1697467488, "published": true}], "snippet": "means the documents produced by ALLPHASE in connection with the Study.", "snippet_links": [{"key": "the-documents", "type": "clause", "offset": [6, 19]}, {"key": "in-connection-with", "type": "clause", "offset": [41, 59]}, {"key": "the-study", "type": "definition", "offset": [60, 69]}], "size": 1, "hash": "bcd63c2b7c8e525372b927827d0acc25", "id": 9}, {"samples": [{"hash": "8qeQiQBK9xJ", "uri": "/contracts/8qeQiQBK9xJ#study-documents", "label": "Clinical Trial Agreement", "score": 27.9288887358, "published": true}], "snippet": "means all records, accounts, CRF, notes, reports, data and IEC/IRB communications (submission, approval and progress reports) collected or generated or used in connection with the Study and/or Study Drug, whether in jinak chr\u00e1niteln\u00e9, nebo ne), autorsk\u00e1 pr\u00e1va a jak\u00e1koli \u2587\u2587\u2587\u2587 pr\u00e1va du\u0161evn\u00edho vlastnictv\u00ed vymy\u0161len\u00e1, uveden\u00e1 do praxe nebo vytvo\u0159en\u00e1 zdravotnick\u00fdm za\u0159\u00edzen\u00edm, zkou\u0161ej\u00edc\u00edm nebo kter\u00fdmkoliv pracovn\u00edkem studie (a\u0165 u\u017e samotn\u00fdm nebo spole\u010dn\u011b s jin\u00fdmi) v pr\u016fb\u011bhu studie nebo jako v\u00fdsledek studie, a/nebo kter\u00e9 se vztahuj\u00ed k materi\u00e1l\u016fm zadavatele nebo jejich pou\u017eit\u00ed. \u201eMateri\u00e1ly zadavatele\u201c znamen\u00e1 jak\u00e9koli za\u0159\u00edzen\u00ed, hodnocen\u00fd l\u00e9\u010div\u00fd p\u0159\u00edpravek, vzorky, slou\u010deniny a/nebo jak\u00e9koliv jin\u00e9 materi\u00e1ly, specifikace, dokumenty nebo informace, ur\u010den\u00e9 na v\u00fdkon slu\u017eeb podle t\u00e9to smlouvy, kter\u00e9 zdravotnick\u00e9mu za\u0159\u00edzen\u00ed nebo zkou\u0161ej\u00edc\u00edmu poskytl zadavatel nebo t\u0159et\u00ed strana jm\u00e9nem zadavatele nebo byly z\u00edsk\u00e1ny spole\u010dnost\u00ed Covance a byly uhrazeny zadavatelem. s n\u00e1zvem \u201eMulticentrick\u00e1, randomizovan\u00e1, dvojit\u011b zaslepen\u00e1, superioritn\u00ed studie s paraleln\u00edmi skupinami, k porovn\u00e1n\u00ed \u00fa\u010dinnosti a bezpe\u010dnosti adjuvantn\u00ed terapie ponesimodem v porovn\u00e1n\u00ed s placebem u pacient\u016f s aktivn\u00ed relabuj\u00edc\u00ed roztrou\u0161enou skler\u00f3zou, l\u00e9\u010den\u00fdch dimethyl-fumar\u00e1tem (Tecfidera\u00ae)\u201c, jak je podrobn\u011b pops\u00e1na v t\u00e9to smlouv\u011b a protokolu. \u201eDokumenty studie\u201c znamenaj\u00ed v\u0161echny z\u00e1znamy, \u00fa\u010dty, CRF, pozn\u00e1mky, protokoly, data a komunikace s EK (p\u0159edlo\u017een\u00ed, schv\u00e1len\u00ed a hl\u00e1\u0161en\u00ed o pokroku), kter\u00e9 byly shrom\u00e1\u017ed\u011bny nebo generov\u00e1ny, nebo se pou\u017e\u00edvaj\u00ed written, electronic, oral or other form including all recorded original observations and notations of clinical activities and all other reports and records necessary for the evaluation and reconstruction of the Study.", "snippet_links": [{"key": "all-records", "type": "clause", "offset": [6, 17]}, {"key": "progress-reports", "type": "definition", "offset": [108, 124]}, {"key": "in-connection-with", "type": "clause", "offset": [157, 175]}, {"key": "the-study", "type": "definition", "offset": [176, 185]}, {"key": "study-drug", "type": "definition", "offset": [193, 203]}, {"key": "pr\u00e1va-du\u0161evn\u00edho-vlastnictv\u00ed", "type": "clause", "offset": [276, 303]}, {"key": "zdravotnick\u00fdm-za\u0159\u00edzen\u00edm", "type": "clause", "offset": [347, 370]}, {"key": "materi\u00e1ly-zadavatele", "type": "clause", "offset": [575, 595]}, {"key": "hodnocen\u00fd-l\u00e9\u010div\u00fd-p\u0159\u00edpravek", "type": "clause", "offset": [624, 650]}, {"key": "clinical-activities", "type": "definition", "offset": [1607, 1626]}, {"key": "other-reports-and-records", "type": "clause", "offset": [1635, 1660]}, {"key": "necessary-for", "type": "definition", "offset": [1661, 1674]}, {"key": "the-evaluation", "type": "clause", "offset": [1675, 1689]}], "size": 1, "hash": "700d3c00d2384285a24fba478f47f8a4", "id": 10}], "next_curs": "ClwSVmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjgLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIYc3R1ZHktZG9jdW1lbnRzIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means the documents produced by POI in connection with the Study that are necessary for the production of the final study report.", "size": 17, "title": "Study Documents", "id": "study-documents", "examples": ["If the Reinsurer does not deliver a Notice of Disagreement to the Company within such thirty (30) day period, the Annual Expense Reimbursement Factor Documents and the Triennial <strong>Study Documents</strong>, as applicable, shall be final and binding upon the parties hereto and shall constitute the final calculation of the Annual Expense Reimbursement Factor for the next calendar year.", "Any changes in the Annual Expense Reimbursement Factor, if any, that are agreed to by the Company and the Reinsurer within sixty (60) days of the aforementioned delivery of the Annual Expense Reimbursement Factor Documents or the Triennial <strong>Study Documents</strong>, as applicable, shall be incorporated into a final calculation of the Annual Expense Reimbursement Factor.", "In the event that the Reinsurer has any disagreement with any of the Annual Expense Reimbursement Factor Documents or the Triennial <strong>Study Documents</strong>, as applicable, the Reinsurer shall give written notice of all such disagreements (a \u201cNotice of Disagreement\u201d) to the Company within thirty (30) days after the Annual Expense Reimbursement Factor Documents or the Triennial <strong>Study Documents</strong>, as applicable, are delivered to the Reinsurer.", "If AbbVie requests that Institution retain the <strong>Study Documents</strong> beyond the Retention Period, the parties shall cooperate in good faith in an effort to mutually agree upon the costs and the duration for such extended retention period.", "Institution shall retain the <strong>Study Documents</strong> in accordance with applicable Laws (the \u201cRetention Period\u201d).", "All <strong>Study Documents</strong> and CRFs will be forwarded to YM after the Study is completed or upon termination of this Agreement.", "YM shall be permitted full access to such <strong>Study Documents</strong> and CRFs at any time upon written request to POI.", "In the event that the Company has any disagreement with any of the Annual Expense Reimbursement Factor Documents or the Triennial <strong>Study Documents</strong>, as applicable, the Company shall give written notice of all such disagreements (a \u201cNotice of Disagreement\u201d) to GNA within thirty (30) days after the Annual Expense Reimbursement Factors Documents or the Triennial <strong>Study Documents</strong>, as applicable, are delivered to the Company.", "Any changes in the Annual Expense Reimbursement Factors, if any, that are agreed to by the Company and GNA within sixty (60) days of the aforementioned delivery of the Annual Expense Reimbursement Factors Documents or the Triennial <strong>Study Documents</strong>, as applicable, shall be incorporated into a final calculation of the Annual Expense Reimbursement Factors.", "If the Company does not deliver a Notice of Disagreement to the Company within such thirty (30) day period, the Annual Expense Reimbursement Factors Documents and the Triennial <strong>Study Documents</strong>, as applicable, shall be final and binding upon the parties hereto and shall constitute the final calculation of the Annual Expense Reimbursement Factors for the next calendar year."], "related": [["rfp-documents", "RFP Documents", "RFP Documents"], ["seller-ancillary-documents", "Seller Ancillary Documents", "Seller Ancillary Documents"], ["regulatory-documents", "Regulatory Documents", "Regulatory Documents"], ["bidding-documents", "Bidding Documents", "Bidding Documents"], ["buyer-documents", "Buyer Documents", "Buyer Documents"]], "related_snippets": [], "updated": "2025-07-06T21:58:41+00:00"}, "json": true, "cursor": ""}}